Men facing prostate cancer surgery often worry about how long they will be in the hospital and how quickly they can return to normal life. A large review looked at 1,997 patients who had robotic-assisted radical prostatectomy. The team compared a newer single-port technique to the standard multiport method. They found that the single-port approach led to significantly shorter time in the operating room console and a hospital stay that was about one and a quarter days shorter. Patients also removed their catheter nearly three days sooner with the single-port method. These are important details for anyone planning their recovery. The single-port surgery did not result in more complications or worse cancer control. The chance of leaving cancer cells behind or the cancer returning was the same for both groups. Functioning after surgery, including bladder control and erections, was also comparable between the two techniques. However, the review noted that most of the data came from older studies with different designs. This mix of study types makes it hard to draw firm conclusions. The findings suggest the newer single-port method is a viable option for select patients. But doctors need more rigorous trials to confirm these results before changing standard practice.
Single-port robotic prostate surgery may speed recovery without hurting cancer outcomes
Photo by Natanael Melchor / Unsplash
What this means for you:
Single-port robotic surgery offers faster recovery with similar cancer outcomes compared to standard multiport approaches. More on Cancer
Acupuncture, ACT, Nutrition Top Non-Drug Interventions for Lung Cancer Top non-drug therapies help lung cancer patients with fatigue and mood
· Jun 1, 2026
Psychosocial interventions show no significant changes in suicidal behavior severity among cancer patients across nine randomized trials Psychosocial support shows weak links to suicide risk in cancer patients
· Jun 1, 2026
Trastuzumab deruxtecan improves PFS vs chemotherapy in HR-positive, HER2-low breast cancer Trial shows T-DXd beats chemo for breast cancer
· Jun 1, 2026
Contrast-enhanced mammography shows 97% sensitivity for mammographic asymmetries in meta-analysis Contrast Mammography Shows High Accuracy For Breast Cancer
· Jun 1, 2026